Association Between Frailty & History of Falls in People with MS
“Falls are a major health concern for people with MS, as more than 50% of individuals living with...
MS
Blacks With MS Are Significantly at Risk for Cardiometabolic Conditions
“MS has long been believed to be more prevalent among White people than Black people, but recent...
Don’t Assume MS Causes All Changes in Patients’ Disability
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Disability Changes in Older Patients with MS May Not be MS-Related
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
Lesion State Modulates Link Between sNfL & Age in Multiple Sclerosis
Prior research has shown that levels of serum neurofilament light (sNfL), a promising biomarker of...
A short-term exercise program in patients with multiple sclerosis: is body mass index important?
Obesity is a health problem that can exacerbate the symptoms of multiple sclerosis (MS). In the current study, we aimed to investigate the effectiveness of a short-term exercise program on fatigue, depression, anxiety, and...
Don’t Assume MS Causes All Changes in Patients’ Disability
As the average age of people with multiple sclerosis (MS) increases, it becomes even more critical...
ACTRIMS-ECTRIMS: Ofatumumab Shows Efficacy in New MS Patients
Once-monthly injections allows patients to control their treatment schedule In a group of...
ACTRIMS-ECTRIMS: Phase 3 EXCHANGE, Insights From Lead Investigator
The interim analysis of the EXCHANGE trial suggest that, for patients with relapsing multiple sclerosis, immediate conversion from oral/injectable disease modifying therapies to siponimod without any washout period (within 24...
ECTRIMS 2020 Encore Event: NG-Specific Biomarkers Can Quickly Differentiate NMOSD from MS
Neutrophil granulocyte (NG)-specific biomarkers have high sensitivity and specificity for rapid differentiation between acute neuromyelitis optica spectrum disorders (NMOSD), anti-MOG-antibody associated disease (MOGAD), and...
ECTRIMS 2020 Encore Event: Interrupting DMT Due to Pregnancy Increases NfL Levels in MS
During pregnancy and the disease-modifying treatment (DMT)-free postpartum period, serum neurofilament-light (sNfL) levels were augmented [1]. This increase was independent of relapses, suggesting increased subclinical disease...
ECTRIMS 2020 Encore Event: Brain Alterations at Onset of First Demyelinating Event
Neurite orientation dispersion and density imaging (NODDI) can detect brain microstructural and metabolic alterations after the first demyelinating event in MS [1]. There was increased axonal dispersion in normal-appearing white...
